- Home
- MDGL vs ZWS Comparison
MDGL vs ZWS Comparison
Compare MDGL & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- ZWS
- Stock Information
- Founded
- MDGL 2011
- ZWS 1891
- Country
- MDGL United States
- ZWS United States
- Employees
- MDGL N/A
- ZWS N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- ZWS Industrial Machinery/Components
- Sector
- MDGL Health Care
- ZWS Industrials
- Exchange
- MDGL Nasdaq
- ZWS Nasdaq
- Market Cap
- MDGL 7.1B
- ZWS 6.1B
- IPO Year
- MDGL N/A
- ZWS 2012
- Fundamental
- Price
- MDGL $336.23
- ZWS $34.88
- Analyst Decision
- MDGL Buy
- ZWS Buy
- Analyst Count
- MDGL 14
- ZWS 6
- Target Price
- MDGL $351.67
- ZWS $38.67
- AVG Volume (30 Days)
- MDGL 357.1K
- ZWS 1.1M
- Earning Date
- MDGL 02-26-2025
- ZWS 02-04-2025
- Dividend Yield
- MDGL N/A
- ZWS 1.03%
- EPS Growth
- MDGL N/A
- ZWS 43.81
- EPS
- MDGL N/A
- ZWS 0.92
- Revenue
- MDGL $76,813,000.00
- ZWS $1,566,500,000.00
- Revenue This Year
- MDGL N/A
- ZWS $4.44
- Revenue Next Year
- MDGL $195.95
- ZWS $5.75
- P/E Ratio
- MDGL N/A
- ZWS $38.33
- Revenue Growth
- MDGL N/A
- ZWS 2.35
- 52 Week Low
- MDGL $189.00
- ZWS $28.25
- 52 Week High
- MDGL $368.29
- ZWS $41.15
- Technical
- Relative Strength Index (RSI)
- MDGL 52.41
- ZWS 27.82
- Support Level
- MDGL $334.13
- ZWS $35.29
- Resistance Level
- MDGL $354.49
- ZWS $36.03
- Average True Range (ATR)
- MDGL 13.20
- ZWS 0.84
- MACD
- MDGL 0.16
- ZWS -0.34
- Stochastic Oscillator
- MDGL 43.12
- ZWS 2.82
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About ZWS Zurn Elkay Water Solutions Corporation
Zurn Elkay Water Solutions Corp designs procure, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The Zurn Elkay product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.